期刊文献+

宫颈癌细胞系Siha和C33a中RRM2表达水平与细胞对吉西他滨敏感性的相关分析 被引量:6

Correlation between RRM2 Expression Level of Cervical Cancer Cell Line Siha and C33a and Cell Sensitivity to Gemcitabine
原文传递
导出
摘要 目的:研究宫颈癌细胞系C33a和Siha中核糖核苷酸还原酶小亚基M2(RRM2)表达与细胞对吉西他滨(Gem)敏感性的相关性。方法:以0.1-3.2μmol/L Gem处理C33a细胞,以0.5-512μmol/L Gem处理Siha细胞,72 h后用MTT法测定细胞活力,计算半数抑制浓度(IC50);使用Western blot法和逆转录-聚合酶链反应检测各细胞中RRM2表达;采用浓度梯度倍增和大剂量冲击相结合的方法对Siha细胞进行Gem耐药诱导培养,构建Siha/Gem耐药细胞株;在Siha/Gem细胞中,使用RNA干扰技术敲低RRM2表达并检测敲低前后Gem对细胞的IC50。结果:Gem对C33a、Siha细胞的IC50分别为0.63、16.8μmol/L。与C33a细胞比较,Siha细胞中RRM2的表达较高。与Siha细胞相比,Siha/Gem耐药细胞(耐药指数为16.26)中RRM2表达增强。Gem对敲低RRM2表达的Siha/Gem耐药细胞的IC50降低,其逆转耐药倍数为4.24。结论:宫颈癌细胞系中RRM2表达可能与细胞对Gem的敏感性呈负相关,敲低RRM2表达可增加细胞对Gem的敏感性。 OBJECTIVE:To study the correlation between RRM2 expression of cervical cancer cell line C33 a and Siha and cell sensitivity to gemcitabine(Gem). METHODS:C33a and Siha were treated with 0.1-3.2 μmol/L and 0.5-512 μmol/L of gemcitabine respectively for 72 h;cell viability was measured by MTT assay to calculate the value of IC50. The expression of RRM2 was measured by Western blot and RT-PCR. Siha cell was treated with gradient concentration and large dose of Gem to establish Siha/Gem drug-resistant cell line. RNA interference technology knockdown the expression of RRM2 in Siha/Gem cell,and IC50 of Gem to cell was determined before and after knockdown. RESULTS:The IC50 values of Gem to Siha and C33 a were 16.8 μ mol/L and 0.63μmol/L. Compared with C33 a cells,the expression of RRM2 in Siha cell was higher. Compared with Siha cells,Siha/Gem drug-resistant cell(drug resistant index of 16.26)showed higher RRM2 expression. Siha/Gem drug-resistant cell knockdown RRM2,IC50 of Gem to it was decreased,and inverse drug resistant times was 4.24. CONCLUSIONS:There is an negative correlation between RRM2 expression and Gem sensitivity in cervical cancer cell lines. The knockdown of RRM2 in Siha/Gem increases the sensitivity to Gem.
出处 《中国药房》 CAS 北大核心 2015年第34期4792-4794,共3页 China Pharmacy
关键词 宫颈癌细胞 C33a SIHA 吉西他滨 核糖核苷酸还原酶小亚基M2 RNA干扰 Cervical cancer cell C33a Siha Gemcitabine Ribonucleotide reductase small subunit M2 RNA interference
  • 相关文献

参考文献8

  • 1Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA:A Cancer J Clin,2015,65(1):5.
  • 2邓雅静,胡杰,杜琳.应用阴道镜筛查宫颈癌前病变的临床分析[J].中国医学创新,2013,10(12):116-117. 被引量:11
  • 3Potter J,Peitzmeier SM,Bernstein I,et al.Cervical cancer screening for patients on the female-to-male spectrum:a narrative review and guide for clinicians[J].J Gen Intern Med,2015,doi:10.1007/S11606-015-3462-8.
  • 4彭茸,赵纯全.化疗药物在宫颈癌治疗中的应用及研究进展[J].中国药房,2013,24(12):1143-1146. 被引量:18
  • 5Shao J,Liu X,Zhu L,et al.Targeting ribonucleotide reductase for cancer therapy[J].Expert Opin Ther Targets,2013,17(12):1 423.
  • 6Lai IL,Chou CC,Lai PT,et al.Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells[J].Carcinogenesis,2014,35(10):2 203.
  • 7Jin G,Zhao J,Qi H,et al.Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis[J].Onco Targets Ther,2013,6(4):1 707.
  • 8Huang P,Chubb S,Hertel LW,et al.Action of 2′,2′-difluorodeoxycytidine on DNA synthesis[J].Cancer Res,1991,51(22):6 110.

二级参考文献13

共引文献27

同被引文献42

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部